GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Calipharms KGET · USD

Industrials · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Calipharms — daily KGET Delayed
Market value
$2,262
Last close × shares
Volume
690k
Shares, 30 Oct 2026

About Calipharms

Its shares trade under the ticker KGET. It has been listed since 13 July 2001.

Kleangas Energy Technologies, Inc. engages in the medical marijuana-cannabis business. The company is headquartered in Tampa, Florida. The company went IPO on 2001-07-13. The firm is engaged in designing, manufacturing and selling oxy-hydrogen systems. These systems function by creating oxygen and hydrogen from distilled water through electrolysis and injecting these gases into the mixture of fuel and air used in gasoline and diesel internal combustion engines. In August 2013, the Company acquired a Patent Pending Oxy-Hydrogen Generator Technology for all types of gas and diesel internal combustion engines. Effective June 27, 2014, the Company announced that it has completed the acquisition of Green Day Technologies, Inc.

Figures and description from our data supplier, not checked against the company's own report.

More about Calipharms →

Latest on Calipharms

Our reporting

We have not reported on Calipharms yet.

Other Industrials listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Calipharms's ticker?

Calipharms trades as KGET on its US listing, under ISIN US4984561021.

What was Calipharms's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.